Latest filing published 14 Jul 2021 for Consun Pharmaceutical Group Ltd..
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -28.1%Entry HK$7.34 · Close at T+365 HK$5.28
- -24.1%Entry HK$7.05 · Close at T+365 HK$5.35
- -37.2%Entry HK$7.85 · Close at T+365 HK$4.93
- -36.4%Entry HK$7.75 · Close at T+365 HK$4.93
- -22.8%Entry HK$7.10 · Close at T+365 HK$5.48
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
An Yubao: trading record in brief
All filings by An Yubao on record concern Consun Pharmaceutical Group Ltd. In total, 11 filings cover trades dated from 19 October 2017 to 9 July 2021.
The open-market side counts 7 purchases for €1.5M alongside 2 sales. The amount is not disclosed for 4 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2021 to date brings no purchases and 1 sale.
In size, the median ticket on the buying side is €39k. 4 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. After 5 purchases with a full 90-day history, the hit rate stands at 20% and the median 90-day move at -12.2%. They describe history only and say nothing certain about the share price ahead.
The latest filing, published on 14 July 2021, reports a transaction in Consun Pharmaceutical Group Ltd. The last insider purchase was made public on 22 June 2020, 2,331 days ago. The median gap between a trade and its publication by HKEX is 3 days. This delay matters because a trade only becomes useful information once it is public. This summary is built from HKEX disclosures alone and does not predict where the share price will go.
Companies and markets linked to An Yubao
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 222,348,817 sharesShareXHKGHKEX:DA20210714E00083
- 1,458,333 sharesShareXHKGHKEX:DA20210326E00292
- 844,000 sharesShareXHKGHKEX:DA20200622E00191Canonical exit: 16 Sept 2020 (T+90)
- 2,916,667 sharesShareXHKGHKEX:DA20200326E00113
- 8,750,000 sharesShareXHKGHKEX:DA20190104E00433Canonical exit: 2 Apr 2019 (T+90)
- 50,000 shares@ HK$7.06682.5% of flowShareXHKGHKEX:DA20180628E00561Canonical exit: 26 Sept 2018 (T+90)
- 1,631,000 shares@ HK$7.439186.3% of flowShareXHKGHKEX:DA20180627E00447Canonical exit: 25 Sept 2018 (T+90)
- 170,000 shares@ HK$7.71639.2% of flowShareXHKGHKEX:DA20180608E00391Canonical exit: 6 Sept 2018 (T+90)
- 30,000 shares@ HK$7.631.6% of flowShareXHKGHKEX:DA20180607E00357Canonical exit: 5 Sept 2018 (T+90)
- 196,674,000 sharesShareXHKGHKEX:DA20180410E00063
- 9,000 shares@ HK$6.480.4% of flowShareXHKGHKEX:DA20171023E00209Canonical exit: 17 Jan 2018 (T+90)
11 of 11 declarations